Search Results
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on October 3, 2022, to shareholders of record as of September 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock.
What is Diabetic Retinopathy?
Diabetic retinopathy can be an invisible, yet life changing condition. That's why it is critical that people living with diabetes have annual vision screenings so that the condition can be detected before it causes vision loss.
Navigating Life with a Complex Condition
For Baxter employee David and his wife Lauren, receiving a complex medical condition diagnosis for their daughter meant facing a reality where her care didn't fit into a box. Through a well-connected support system and ability to provide care at home, they have forged their own path.
Baxter Details Progress Toward Environmental, Social and Governance (ESG) Priorities in Annual Corporate Responsibility Report
Baxter International Inc. (NYSE:BAX), a global medtech leader, today released its 2021 Corporate Responsibility Report, demonstrating how the company is progressing toward its 2030 Corporate Responsibility Commitment and Goals.
Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2022 financial results on Thursday, July 28, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information.
Baxter to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022. José (Joe) Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 10:40 a.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 13, 2023.
Point of Pride with Every Bag
We spoke with Diana, Plant Director of our Haina, Dominican Republic facility, to share perspectives on our employees' connection to our products and her career trajectory. The Haina facility opened in 2012 and today has more than 900 employees. The IV bags made there are distributed globally and used throughout hospitals to help patients.
Supporting Patients in Extraordinary Times
Continuous renal replacement therapy (CRRT) is the cornerstone of treatment in patients with severe acute kidney injury (AKI), one of many complications affecting COVID-19 patients. Throughout the pandemic, Baxter has been doing all it can to help meet the increased need for CRRT products, including filter sets used to remove fluid and uremic toxins from the patient’s blood during CRRT before the cleaned blood is returned to the body.
Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will showcase its ongoing trajectory of transformation and growth at its 2022 Investor Conference, being held today in Glenview, Ill. The company's executive leadership team will highlight Baxter’s strategy to continue creating compelling value for patients, clinicians and investors through leading-edge innovation, market expansion, operational efficiency and other vital growth levers.
Building Bridges to Elevate Inclusivity
Connecting with Baxter's resource group for Asian employees